Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Molecular Cancer Research : MCR|June 14, 2011
Notch1 inhibition alters the CD44hi/CD24lo population and reduces the formation of brain metastases from breast cancerPatricia M McGowan, Carmen Simedrea, Emeline J Ribot, et al.
Breast Cancer Research and Treatment|December 22, 2007
The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanismsErika B Schulze, Benjamin D Hedley, David Goodale, et al.
International Journal of Molecular Sciences|September 13, 2016
Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial IncorporationLori E Lowes, Scott V Bratman, Ryan Dittamore, et al.
Journal of Pharmaceutical Sciences|December 12, 2018
Magnetically Guided Self-Assembled Protein Micelles for Enhanced Delivery of Dasatinib to Human Triple-Negative Breast Cancer CellsSally A Sabra, Salah A Sheweita, Medhat Haroun, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 25, 2018
Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and wogonin to breast cancerSally A Sabra, Ahmed O Elzoghby, Salah A Sheweita, et al.
International Journal of Cancer|May 13, 2008
Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1Benjamin D Hedley, Danny R Welch, Alison L Allan, et al.
Molecular Cancer Research : MCR|October 1, 2003
Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontinKara A Furger, Alison L Allan, Sylvia M Wilson, et al.
Annals of Surgical Oncology|December 31, 2015
Central, But Not Peripheral, Circulating Tumor Cells are Prognostic in Patients Undergoing Resection of Colorectal Cancer Liver MetastasesAshton A Connor, Kate McNamara, Eisar Al-Sukhni, et al.
Cancers|October 29, 2025
Artemis (DCLRE1C) Acts as a Target to Enhance Radiotherapy Response in Triple-Negative Breast CancerVasudeva Bhat, Kelsie L Thu, Anayra de Fatima Goncalves Santiago, et al.
Pageof 7